Why the study?
Further studies were needed to establish the clinical utility of hemostasis, inflammation, and adhesion molecule parameters as adjuvant markers for cardiovascular risk in T2DM patients.
T2DM and poor glycemic control are associated with alterations in hemostasis, inflammation, and adhesion molecules, which may serve as markers for cardiovascular risk.
Authors
No takes yet. Share an insight, caveat, or question.
May inform CV risk stratification in T2DM; hypothesis-generating and leaves causal effects of glycemic control open.
Palella et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: